Obesity Drugs
McKenzie Prillaman reports on semaglutide (Ozempic), a promising obesity drug from Novo Nordisk. She also addresses the cost of such medication regime, which is projected to be over $1,000/month.
-DDLabels: Semaglutide, Weight loss
posted by David Dial | 8:35 AM
0 Comments:
Post a Comment
<< Home